US 9,029,322 · Application 12/663,091 · Granted May 12, 2015
US 9,029,322
Compounds for enhancing p21 expression and methods of use thereof
Estimated expiration
February 21, 2030
3y 137d remaining
Earliest effective filing
Jun 5, 2008
+ 20 years
Jun 5, 2028
PTA +626d
Feb 21, 2030
No TD
—
Final
Feb 21, 2030
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- March 22, 2010
- Earliest effective filing
- June 5, 2008
- Issue date
- May 12, 2015
- PTA
- +626 days
- Base expiry (before PTA)
- June 5, 2028
June 5, 2008 + 20 years = June 5, 2028 + 626 PTA days = February 21, 2030
- National stage entry of application PCTUS2008007168, filed Jun 5, 2008
- PRO60/933,366 — Provisional — not used for base term
- PRO60/933,366 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 12/663,091 · US 9,029,322
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,029,322: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9029322Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.